Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.
Aims to drive the quality, accuracy, and integrity of clinical trial data as well as increase productivity, efficiency and cost effectiveness for sponsors